MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,530 | +180.2% | 1,476 | +343.2% | 0.00% | – |
| Q2 2023 | $76,923 | +24.0% | 333 | +30.1% | 0.00% | – |
| Q1 2023 | $62,010 | -58.3% | 256 | -50.0% | 0.00% | – |
| Q4 2022 | $148,581 | +132.2% | 512 | -47.6% | 0.00% | – |
| Q3 2022 | $64,000 | -9.9% | 977 | -1.1% | 0.00% | – |
| Q2 2022 | $71,000 | -30.4% | 988 | -4.8% | 0.00% | – |
| Q1 2022 | $102,000 | +30.8% | 1,038 | +11.0% | 0.00% | – |
| Q4 2021 | $78,000 | +11.4% | 935 | +8.0% | 0.00% | – |
| Q3 2021 | $70,000 | +133.3% | 866 | +183.0% | 0.00% | – |
| Q2 2021 | $30,000 | 0.0% | 306 | +17.2% | 0.00% | – |
| Q1 2021 | $30,000 | -16.7% | 261 | -19.4% | 0.00% | – |
| Q4 2020 | $36,000 | +125.0% | 324 | +134.8% | 0.00% | – |
| Q3 2020 | $16,000 | +45.5% | 138 | +38.0% | 0.00% | – |
| Q2 2020 | $11,000 | -68.6% | 100 | -80.9% | 0.00% | – |
| Q1 2020 | $35,000 | – | 523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |